Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 49
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 47
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

LEXENPHARM

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 49
  • 0 comments

FDA approve FORMOTEROL FUMARATE

Comment Full text

SUN PHARM

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 49
  • 0 comments

FDA approve ALFUZOSIN HYDROCHLORIDE

Comment Full text

MSN

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 54
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 52
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

OSMOTICA PHARM US

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 47
  • 0 comments

FDA approve CARBAMAZEPINE

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 42
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Oct. 23, 2024, 08:47 UTC
  • 44
  • 0 comments

FDA approve ICATIBANT ACETATE

Comment Full text

MANKIND PHARMA

  • FDA Approval
  • Oct. 23, 2024, 04:10 UTC
  • 42
  • 0 comments

FDA approve LEVALBUTEROL HYDROCHLORIDE

Comment Full text
  • Previous
  • 328
  • 329
  • 330
  • 331
  • 332
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216327)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137444)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin